David Springer

7PUBLICATIONS
16CO-AUTHORS
Non-genetically modified uses of biotechnologyNanotoxicology, health and safetyMedical molecular engineering of nucleic acids and proteinsNanomedicineMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 26, 2024
The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines.

Inna Tulaeva, Felix Lehmann, Nora Goldmann

|Apr 26, 2024
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection.

David Niklas Springer, Simon Daller, Michael Knappik

|Jan 22, 2024
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray.

David Niklas Springer, Eva Höltl, Katja Prüger

|Aug 04, 2023
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants.

David N Springer, Michael Bauer, Iris Medits

|Jul 14, 2023
A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection.

David Niklas Springer, Marianna Traugott, Elisabeth Reuberger

|Feb 09, 2023
Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage.

Christoph Buchta, David Springer, Jovana Jovanovic

Pageof 2

Frequent Collaborators

4 joint publications

Judith Helene Aberle

4 joint publications

Lukas Weseslindtner

3 joint publications

Karin Stiasny

2 joint publications

Christoph Buchta